Article
Mutation in the L3 Ribosomal Protein Could Be Associated with Risk of Selection of High-Level Linezolid-Resistant Staphylococcus epidermidis Strains.
Microbial drug resistance (Larchmont, N.Y.) - 1 Jun 2017
Rouard Caroline, Aslangul Elisabeth, Rivière Alexandre, Deback Claire, Butel Marie-José, Doucet-Populaire Florence, Bourgeois-Nicolaos Nadège
Abstract excerpt
Linezolid (LZD) has arisen as an alternative treatment in diabetic foot osteitis due to staphylococci. LZD resistance selection is difficult and involved various molecular mechanisms. As a better knowledge of those mechanisms could be beneficial for pathogenic strains' screening, we simulated in vitro the spontaneous mutagenesis process that leads to LZD-resistant strains from two Staphylococcus epidermidis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
